International Journal of Clinical Pharmacy

, Volume 40, Issue 5, pp 1106–1115 | Cite as

Pharmacist views and pharmacy capacity to deliver professional services in the United Arab Emirates

  • Hamzah AlzubaidiEmail author
  • Ward Saidawi
  • Kevin Mc Namara
Research Article


Background The benefits of professional pharmacy services in improving patient outcomes and reducing health expenditure are well documented. To a large extent, these services are not implemented in many developing countries. Objective To explore pharmacists’ perceptions of and willingness to provide professional services in the United Arab Emirates (UAE) and the perceived barriers and facilitators. The current provision of pharmacy-based services and capacity for service delivery were also explored. Setting Community pharmacies in Sharjah and Dubai in the UAE. Methods A 34-item cross-sectional survey was conducted. It assessed community pharmacists’ perceptions of and willingness to provide professional services in the future, current service provision and capacity to deliver professional services. A descriptive analysis of responses was undertaken. Main outcome measure Community pharmacists' perceptions of and willingness to provide pharmacy-based professional services in the United Arab Emirates (UAE) and associated barriers and facilitators. Results Overall, 200 community pharmacists completed the survey. Ninety-two percent of participants thought that it is time for community pharmacists to engage in extended services (screening, medication use reviews, and chronic disease management) provided that adequate training and regulatory approvals are given. The current restrictive legislations and negative public perception were perceived as major barriers to providing extended services, but lack of time and support staff were also considered barriers. Conclusions Community pharmacists held strong positive views regarding future engagement in professional services. Given the compelling public health case for expansion of affordable care, it is timely to expand health services in the UAE by using the untapped clinical skills of pharmacists. Transition towards professional pharmacy services requires support from key stakeholders including medical and regulatory organizations, and public acceptance.


Community pharmacy Community pharmacy services Perceptions Pharmacist United Arab Emirates Views 



The authors are grateful to all participating pharmacists for sharing insights into the possibility of expanding pharmacy-based health services. The authors gratefully acknowledge Ms. Rania Adnan Atom, Ms. Tasneem Basim Al-Hamidi, and Mr. Bakri Omar Sawas for devoting their time and efforts towards data collection.



Conflicts of interest

All the authors have read and approved the manuscript. The authors declare that they have no financial or other competing interests in relation to their work.

Supplementary material

11096_2018_662_MOESM1_ESM.docx (50 kb)
Supplementary material 1 (DOCX 49 kb)


  1. 1.
    Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm U S. 1990;47:533–43.Google Scholar
  2. 2.
    Taylor K, Harding G. Introduction. In: Taylor K, Harding G, editors. Pharmacy practice (Granada). 2nd ed. Boca Raton: CRC Press; 2015.Google Scholar
  3. 3.
    McDonald R, Cheraghi-Sohi S, Sanders C, Ashcroft D. Professional status in a changing world: the case of medicines use reviews in English community pharmacy. Soc Sci Med Engl. 2010;71:451–8.CrossRefGoogle Scholar
  4. 4.
    Pape GA, Hunt JS, Butler KL, Siemienczuk J, LeBlanc BH, Gillanders W, et al. Team-based care approach to cholesterol management in diabetes mellitus: two-year cluster randomized controlled trial. Arch Intern Med US. 2011;171:1480–6.CrossRefGoogle Scholar
  5. 5.
    Robinson JD, Segal R, Lopez LM, Doty RE. Impact of a pharmaceutical care intervention on blood pressure control in a chain pharmacy practice. Ann Pharmacother US. 2010;44:88–96.CrossRefGoogle Scholar
  6. 6.
    Isetts BJ, Schondelmeyer SW, Heaton AH, Wadd WB, Hardie NA, Artz MB. Effects of collaborative drug therapy management on patients’ perceptions of care and health-related quality of life. Res Soc Adm Pharm US. 2006;2:129–42.CrossRefGoogle Scholar
  7. 7.
    Planas LG, Crosby KM, Farmer KC, Harrison DL. Evaluation of a diabetes management program using selected HEDIS measures. J Am Pharm Assoc. 2012;52:e130–1388.CrossRefGoogle Scholar
  8. 8.
    Fox D, Ried LD, Klein GE, Myers W, Foli K. A medication therapy management program’s impact on low-density lipoprotein cholesterol goal attainment in Medicare Part D patients with diabetes. J Am Pharm Assoc. 2009;49:192–9.CrossRefGoogle Scholar
  9. 9.
    Houle SKD, Grindrod KA, Chatterley T, Tsuyuki RT. Paying pharmacists for patient care: a systematic review of remunerated pharmacy clinical care services. Can Pharm J CPJ. 2014;147:209–32.CrossRefGoogle Scholar
  10. 10.
    Smith M, Giuliano MR, Starkowski MP. In Connecticut: improving patient medication management in primary care. Health Aff. 2011;30:646–54.CrossRefGoogle Scholar
  11. 11.
    Giberson S, Yoder S, Lee M. Improving patient and health system outcomes through advanced pharmacy practice. A report to the U.S. Surgeon General [Internet]. 2011. Accessed 12 Nov 2017.
  12. 12.
    Manolakis PG, Skelton JB. Pharmacists’ contributions to primary care in the United States collaborating to address unmet patient care needs: the emerging role for pharmacists to address the shortage of primary care providers. Am J Pharm Educ. 2010;74:S7.CrossRefGoogle Scholar
  13. 13.
    Lynas K. Professionals you can trust: pharmacists top the list again in Ipsos Reid survey. Can Pharm J CPJ. 2012;145:55.Google Scholar
  14. 14.
    Traulsen JM, Bissell P. (9) Theories of professions and the pharmacist. Int J Pharm Pract. 2014;12:107–14. Scholar
  15. 15.
    Hermansyah A, Sainsbury E, Krass I. Investigating influences on current community pharmacy practice at micro, meso, and macro levels. Res Soc Adm Pharm. 2016;13:727–37.CrossRefGoogle Scholar
  16. 16.
    Roberts AS, Benrimoj SIC, Chen TF, Williams KA, Hopp TR, Aslani P. Understanding practice change in community pharmacy: a qualitative study in Australia. Res Soc Adm Pharm. 2005;1:546–64.CrossRefGoogle Scholar
  17. 17.
    Moullin JC, Sabater-Hernandez D, Fernandez-Llimos F, Benrimoj SI. Defining professional pharmacy services in community pharmacy. Res Soc Adm Pharm. 2013;9:989–95.CrossRefGoogle Scholar
  18. 18.
    Edmunds J, Calnan MW. The reprofessionalisation of community pharmacy? An exploration of attitudes to extended roles for community pharmacists amongst pharmacists and General Practioners in the United Kingdom. Soc Sci Med Engl. 2001;53:943–55.CrossRefGoogle Scholar
  19. 19.
    Anderson S. The state of the world’s pharmacy: a portrait of the pharmacy profession. J Interprof Care Engl. 2002;16:391–404.CrossRefGoogle Scholar
  20. 20.
    McMillan SS, Wheeler AJ, Sav A, King MA, Whitty JA, Kendall E, et al. Community pharmacy in Australia: a health hub destination of the future. Res Soc Adm Pharm. 2013;9:863–75.CrossRefGoogle Scholar
  21. 21.
    Sadek MM, Elnour AA, Al Kalbani NMS, Bhagavathula AS, Baraka MA, Aziz AMA, et al. Community pharmacy and the extended community pharmacist practice roles: the UAE experiences. Saudi Pharm J SPJ. 2016;24:563–70.CrossRefGoogle Scholar
  22. 22.
    Dameh M. Pharmacy in the United Arab Emirates. South Med Rev. 2009;2:15.PubMedPubMedCentralGoogle Scholar
  23. 23.
    Hasan S, Sulieman H, Chapman C, Stewart K, Kong DCM. Community pharmacy in the United Arab Emirates: characteristics and workforce issues. Int J Pharm Pract Engl. 2011;19:392–9.CrossRefGoogle Scholar
  24. 24.
    Ghazal RM, Hassan NAG, Al Ahdab OG, Saliem II. Barriers to the implementation of pharmaceutical care into the UAE community pharmacies. IOSR J Pharm. 2014;4:68–74.Google Scholar
  25. 25.
    Rayes IK, Hassali MA, Abduelkarem AR. Perception of community pharmacists towards the barriers to enhanced pharmacy services in the healthcare system of Dubai: a quantitative approach. Pharm Pract (Granada). 2015;13:506.CrossRefGoogle Scholar
  26. 26.
    Hasan S, Sulieman H, Chapman CB, Stewart K, Kong DCM. Community pharmacy services in the United Arab Emirates. Int J Pharm Pract Engl. 2012;20:218–25.CrossRefGoogle Scholar
  27. 27.
    UAE Diabetes Trends and Numbers [Internet]. 2016 [cited 2017 May 23]. Accessed 12 Nov 2017.
  28. 28.
    United Arab Emirates-World Health Organization-Noncommunicable Diseases (NCD) Country Profiles [Internet]. 2014 [cited 2017 May 23]. Accessed 12 Nov 2017.
  29. 29.
    Alzubaidi H, Mc Mamara K, Chapman C, Stevenson V, Marriott J. Medicine-taking experiences and associated factors: comparison between Arabic-speaking and caucasian English-speaking patients with type 2 diabetes. Diabet Med Engl. 2015;32:1625–33.CrossRefGoogle Scholar
  30. 30.
    Alzubaidi H, Mc Narmara K, Kilmartin GM, Kilmartin JF, Marriott J. The relationships between illness and treatment perceptions with adherence to diabetes self-care: a comparison between Arabic-speaking migrants and caucasian English-speaking patients. Diabetes Res Clin Pract Irel. 2015;110:208–17.CrossRefGoogle Scholar
  31. 31.
    Alzubaidi H, Mc Namara K, Browning C, Marriott J. Barriers and enablers to healthcare access and use among Arabic-speaking and Caucasian English-speaking patients with type 2 diabetes mellitus: a qualitative comparative study. BMJ Open 2015;5. Accessed 12 Nov 2017.
  32. 32.
    Mak VSL, Clark A, Poulsen JH, Udengaard KU, Gilbert AL. Pharmacists’ awareness of Australia’s health care reforms and their beliefs and attitudes about their current and future roles. Int J Pharm Pract Engl. 2012;20:33–40.CrossRefGoogle Scholar
  33. 33.
    Hasan S, Sulieman H, Stewart K, Chapman CB, Hasan MY, Kong DCM. Assessing patient satisfaction with community pharmacy in the UAE using a newly-validated tool. Res Soc Adm Pharm US. 2013;9:841–50.CrossRefGoogle Scholar
  34. 34.
    Babiker AH, Carson L, Awaisu A. Medication use review in Qatar: are community pharmacists prepared for the extended professional role? Int J Clin Pharm Netherlands. 2014;36:1241–50.CrossRefGoogle Scholar
  35. 35.
    Stewart DC, George J, Bond CM, Diack HL, McCaig DJ, Cunningham S. Views of pharmacist prescribers, doctors and patients on pharmacist prescribing implementation. Int J Pharm Pract. 2010;17:89–94. Scholar
  36. 36.
    Kaczorowski J, Chambers LW, Dolovich L, Paterson JM, Karwalajtys T, Gierman T, Farrell B, McDonough B, Thabane L, Tu K. Improving cardiovascular health at population level: 39 community cluster randomised trial of Cardiovascular Health Awareness Program (CHAP). BMJ 2011;342. Accessed 12 Nov 2017.
  37. 37.
    Chen TF. Pharmacist-led home medicines review and residential medication management review: the Australian model. Drugs Aging. 2016;33:199–204.CrossRefGoogle Scholar
  38. 38.
    Latif A, Waring J, Watmough D, Barber N, Chuter A, Davies J, Salema NE, Boyd MJ, Elliott RA. Examination of England’s new medicine service (NMS) of complex health care interventions in community pharmacy. Res Soc Adm Pharm. 2018;12:966–89. Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Hamzah Alzubaidi
    • 1
    Email author
  • Ward Saidawi
    • 1
  • Kevin Mc Namara
    • 2
    • 3
    • 4
  1. 1.Sharjah Institute for Medical Research and College of PharmacyUniversity of SharjahSharjahUnited Arab Emirates
  2. 2.School of MedicineDeakin UniversityWaurn PondsAustralia
  3. 3.Centre for Population Health ResearchDeakin UniversityBurwoodAustralia
  4. 4.Centre for Medicine Use and SafetyMonash UniversityParkvilleAustralia

Personalised recommendations